by Skrydalewicz Maciej | Apr 13, 2020
CORONA 30 ECMO Cannulation, ECMO staffing and ECMO Specialists Extracorporeal Membrane Oxygenation CORONA 30 Part 1 — Thursday Topics: ECMO Cannulation ECMO staffing and ECMO Specialists #extracorporealmembraneoxygenation #ECMO #cannulation This program will discuss...
by Skrydalewicz Maciej | Apr 13, 2020
CORONA 30 Part 1 — Wednesday #perfusion #TCD #stroke Topics: TCD Cerebral Embolic Protection This program will discuss stroke rates in cardiac surgery and endovascular procedures. What is the latest data on cerebral embolic protection and how can transcranial Doppler...
by Skrydalewicz Maciej | Apr 7, 2020 | News & Announcements
Hello, I am Joe Basha, the host of PerfWeb.US and PerfusionEducation.com #perfusion #coronavirus #Covid19 Register and watch for free library.perfusioneducation.com By now, your professional perfusion life, like mine, has been impacted by the latest Covid-19...
by Skrydalewicz Maciej | Apr 2, 2020
CORONA 30 Part 1 Tuesday – Perfusion Meeting 2020 Topics: CORONA 30 Passive antibody therapy, Continuous VenoVenous Hemofiltration CVVH. Passive antibody therapy CVVH This program will discuss antibody transmission via homologous plasma transfer #perfusion #CVVH...
by Skrydalewicz Maciej | Mar 30, 2020 | ECMO, Heart Surgery
BOSTON, MASSACHUSETTS – March 15, 2020 — BIOXYTRAN, INC., (OTC: BIXT) a developmental stage biotechnology company with a pipeline of anti-necrosis drugs designed to treat hypoxia by delivering a small molecule carrying oxygen to the brain of stroke victims...
